Alanine administration does not stimulate gluconeogenesis in preterm infants.

Area of Science:

• Neonatal Physiology
• Metabolic Regulation
• Pediatric Endocrinology

Background:

• Gluconeogenesis, the synthesis of glucose, is vital for maintaining blood glucose homeostasis.
• Preterm infants often have low plasma alanine concentrations, a key gluconeogenic precursor.
• Hypoglycemia is a significant clinical concern in preterm neonates, necessitating strategies to enhance glucose production.

Purpose of the Study:

• To investigate the effect of exogenous alanine administration on gluconeogenesis in preterm infants.
• To determine if increasing precursor supply can stimulate glucose production in this vulnerable population.

Main Methods:

• Utilized the [6,6-(2)H(2)]glucose dilution technique to measure glucose production rate (GPR).
• Employed mass isotopomer distribution analysis with [2-(13)C]glycerol to quantify gluconeogenesis.
• Compared a group of preterm infants receiving alanine infusion with a control group.

Main Results:

• Alanine administration significantly increased plasma alanine concentrations but did not alter the rate of gluconeogenesis or GPR.
• Neither gluconeogenesis nor glucose production rate differed between the alanine-treated group and the control group.
• Observed gluconeogenesis rates of 4.0 ± 0.3 µmol·kg⁻¹·min⁻¹ and GPR of 8.3 ± 0.6 µmol·kg⁻¹·min⁻¹ in controls.

Conclusions:

• Exogenous alanine administration does not stimulate gluconeogenesis in preterm infants.
• Potential limiting factors include restricted enzymatic capacity within the gluconeogenic pathway or insufficient secretion of glucoregulatory hormones.
• Findings suggest alternative strategies may be needed for preventing hypoglycemia in preterm neonates.